Market Cap (In USD)
19.31 Million
Revenue (In USD)
97.29 Million
Net Income (In USD)
-22.75 Million
Avg. Volume
161.09 Thousand
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.065-0.29
- PE
- -
- EPS
- -
- Beta Value
- 3.07
- ISIN
- CA13809L1094
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Robert Beasley
- Employee Count
- -
- Website
- https://www.getfluent.com
- Ipo Date
- 2021-01-08
- Details
- Cansortium Inc., through its subsidiaries, produces and sells medical cannabis in the United States. The company engages in the cultivation, processing, retail, and distribution activities. Its medical cannabis products are offered in oral drops, capsules, suppositories, topicals, syringes, dried flower, prerolls, cartridges, and edibles. The company provides its products under the Fluent brand name. As of August 20, 2021, it operated 28 dispensaries. Cansortium Inc. was incorporated in 2018 and is headquartered in Miami, Florida.
More Stocks
-
CIVB
-
BKNIYBankinter, S.A.
BKNIY
-
0XNHDocuSign, Inc.
0XNH
-
SYPSynopsys, Inc.
SYP
-
TRVGtrivago N.V.
TRVG
-
9264Puequ CO.,LTD.
9264
-
HBC1HSBC Holdings plc
HBC1
-
OPGXOptigenex Inc.
OPGX